Image

Parkinsonian Patients Treated With Apomorphine Pump: Observatory of Skin Lesions

Parkinsonian Patients Treated With Apomorphine Pump: Observatory of Skin Lesions

Recruiting
18 years and older
All
Phase N/A

Overview

Treatment with subcutaneous apomorphine will be initiated according to the usual procedures at each centre. Once the patient is included in the study, he/she will be followed for 24 months according to a schedule of visits corresponding to his/her follow-up care.

The procedures outside of the patient's usual care are only more in-depth clinical assessments and examinations (interviews with a nurse, skin lesion assessment scale, quality of life scales, neurological and cognitive assessment scales).

At each visit, the patient will be seen in consultation by a state-qualified nurse from the neurology department who will conduct

  • nursing interviews to assess tolerance and compliance with treatment. She will also look for data concerning the flow rate, the duration of the subcutaneous apomorphine pump and the injection methods (material used, rotation of injection sites, massages).
  • collection of adverse effects and changes in concomitant treatments.
  • assessment of skin complications (number, location, characteristics: size, pain, inflammation).

For centres that do not have a nurse dedicated to monitoring these patients, the above procedure will be carried out by the neurologist.

In all cases, the patient will receive a consultation (in the department or remotely) by the neurologist.

The tests and scales performed at inclusion will be repeated at each six-monthly visit.

Eligibility

Inclusion Criteria:

  • Age greater than or equal to 18 years,
  • Diagnosis of Parkinson's disease according to the MDS criteria (2015),
  • Patients with a prescription for subcutaneous apomorphine pump therapy,
  • Patient having read and understood the information letter and having expressed oral non-opposition to the research.

Exclusion Criteria:

  • Patient unable to express opposition or non-opposition,
  • Patient not affiliated to the social security system,
  • Pregnant woman or woman in labour or breastfeeding,
  • Person deprived of liberty by an administrative or judicial decision,
  • Person placed under court protection, guardianship or curatorship.

Study details
    Patients With Parkinson's Disease Treated With Apomorphine Pumps

NCT05331573

University Hospital, Rouen

13 December 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.